Effect of a Fermented Milk Combining Lactobacillus Acidophilus CL1285 and Lactobacillus Casei in the Prevention of Antibiotic-Associated Diarrhea: A Randomized, Double-Blind, Placebo-Controlled Trial
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Antibiotic-associated diarrhea is an important problem in hospitalized patients. The use of probiotics is gaining interest in the scientific community as a potential measure to prevent this complication. The main objective of the present study was to assess the efficacy and safety of a fermented milk combining Lactobacillus acidophilus and Lactobacillus casei that is widely available in Canada, in the prevention of antibiotic-associated diarrhea. METHODS: In this double-blind, randomized study, hospitalized patients were randomly assigned to receive either a lactobacilli-fermented milk or a placebo on a daily basis. RESULTS: Among 89 randomized patients, antibiotic-associated diarrhea occurred in seven of 44 patients (15.9%) in the lactobacilli group and in 16 of 45 patients (35.6%) in the placebo group (OR 0.34, 95% CI 0.125 to 0.944; P=0.05). The median hospitalization duration was eight days in the lactobacilli group, compared with 10 days in the placebo group (P=0.09). Overall, the lactobacilli-fermented milk was well tolerated. CONCLUSION: The daily administration of a lactobacilli-fermented milk was safe and effective in the prevention of antibiotic-associated diarrhea in hospitalized patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



















Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Five studies examined AAD as a primary end point, with four studies of two different probiotics showing a significant reduction in AAD,40–43 and one underpowered study of another probiotic showing a nonsignificant reduction.45”
From Systematic review: probiotics in the management of lower gastrointestinal symptoms in clinical practice - an evidence-based international guide (2013) · cites this paper as [40]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antibiotic-Associated Diarrhea
Bartlett, J. G. (2002) · New England Journal of Medicine · doi:10.1056/nejmcp011603 · Cited by 1,197 · cited 4×
“6% [seven of 16 cases] in the placebo group versus 10% to 20%) (1,3-5).”
BackgroundInfluentialProbiotics: effects on immunity
Isolauri, E., Sütas, Y., Kankaanpää, P., Arvilommi, H., & Salminen, S. (2001) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/73.2.444s · Cited by 1,019 · cited 1×
“for gastrointestinal (GI) colonization and available nutrients, and immunomodulation (7,9-11,13-15).”
BackgroundProbiotics in prevention of antibiotic associated diarrhoea: meta-analysis
D'Souza, A. L., Rajkumar, C., Cooke, J., & Bulpitt, C. J. (2002) · BMJ · doi:10.1136/bmj.324.7350.1361 · Cited by 664 · cited 3×
“Exclusion criteria included active diarrhea at enrollment, diagnosis of C difficile-associated diarrhea (CDAD) within the previous three months, antibiotic treatment with vancomycin or an aminoglycoside in monotherapy (23), confirmed lactose intolerance, underlying chronic GI tract disease, patients with stomas, use o…”
BackgroundMethodPrevention of antibiotic-associated diarrhea by Saccharomyces boulardii: A prospective study
Surawicz, C. M., Elmer, G. W., Speelman, P., McFarland, L. V., Chinn, J., & Van Belle, G. (1989) · Gastroenterology · doi:10.1016/0016-5085(89)91613-2 · Cited by 573
Safety of Probiotics That Contain Lactobacilli or Bifidobacteria
Borriello, S. P., Hammes, W. P., Holzapfel, W., Marteau, P., Schrezenmeir, J., Vaara, M., & Valtonen, V. (2003) · Clinical Infectious Diseases · doi:10.1086/368080 · Cited by 551 · cited 1×
“It is noteworthy that lactobacilli have a long record of safety and have been used for many years in the fermentation process of multiple food products (21,22).”
BackgroundArvola, T., Laiho, K., Torkkeli, S., Mykkänen, H., Salminen, S., Maunula, L., & Isolauri, E. (1999) · Pediatrics · doi:10.1542/peds.104.5.e64 · Cited by 427 · cited 1×
“Several studies have investigated the efficacy of prophylactic probiotics in preventing AAD but the heterogeneity of the strains and formulation used limit their external validity (5,6,9-12,15-19).”
BackgroundClostridium difficile-associated diarrhea in adults
Poutanen, S. M. (2004) · Canadian Medical Association Journal · doi:10.1503/cmaj.1031189 · Cited by 410 · cited 3×
“6% [seven of 16 cases] in the placebo group versus 10% to 20%) (1,3-5).”
BackgroundMeta‐analysis: the effect of probiotic administration on antibiotic‐associated diarrhoea
Cremonini, F., Di Caro, S., Nista, E. C., Bartolozzi, F., Capelli, G., Gasbarrini, G., & Gasbarrini, A. (2002) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2002.01318.x · Cited by 384 · cited 3×
“Several studies have investigated the efficacy of prophylactic probiotics in preventing AAD but the heterogeneity of the strains and formulation used limit their external validity (5, 6 ,9-12,15-19).”
BackgroundInfluentialPrevention of beta-lactam-associated diarrhea by Saccharomyces boulardii compared with placebo.
McFarland, L. V., Surawicz, C. M., Greenberg, R. N., Elmer, G. W., Moyer, K. A., Melcher, S. A., Bowen, K., & Cox, J. L. (1995) · PubMed · Cited by 383
Probiotic agents and infectious diseases: a modern perspective on a traditional therapy
Alvarez-Olmos, M. I., & Oberhelman, R. A. (2001) · Clinical Infectious Diseases · doi:10.1086/320518 · Cited by 359 · cited 3×
“Exclusion criteria included active diarrhea at enrollment, diagnosis of C difficile-associated diarrhea (CDAD) within the previous three months, antibiotic treatment with vancomycin or an aminoglycoside in monotherapy (23), confirmed lactose intolerance, underlying chronic GI tract disease, patients with stomas, use o…”
Background
Research works printed but not linked: 2
- Surawicz CM, Elmer GW, Speelman P, McFarland LV, Chinn J, van Belle G. Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii. Gastroenterology 1989;96:981-8.
- Adam J, Barret A, Barret-Bellet C. Essais cliniques contrôlés en double insu de l'Ultra-levure lyophilisée: étude multicentrique par 25 médecins de 388 cas. Gaz Med Fr 1977;84:2072-8.
Cited by
Newberry, S. J. (2012) · JAMA · doi:10.1001/jama.2012.3507 · Cited by 870
“68) Safdar,46 2008 4/23 (17) 6/17 (35) 0.”
BackgroundInfluentialProbiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children
Goldenberg, J. Z., Ma, S. S., Saxton, J. D., Martzen, M. R., Vandvik, P. O., Thorlund, K., Guyatt, G. H., & Johnston, B. C. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006095.pub3 · Cited by 741
McFarland, L. V., Evans, C. T., & Goldstein, E. J. C. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00124 · Cited by 609
Probiotics for the prevention of pediatric antibiotic-associated diarrhea
Goldenberg, J. Z., Lytvyn, L., Steurich, J., Parkin, P., Mahant, S., & Johnston, B. C. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004827.pub4 · Cited by 607
Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children
Goldenberg, J. Z., Yap, C., Lytvyn, L., Lo, C. K.-F., Beardsley, J., Mertz, D., & Johnston, B. C. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006095.pub4 · Cited by 550
Allen, S. J., Wareham, K., Wang, D., Bradley, C., Hutchings, H., Harris, W., Dhar, A., Brown, H., Foden, A., Gravenor, M. B., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61218-0 · Cited by 383
Johnston, B. C., Ma, S. S. Y., Goldenberg, J. Z., Thorlund, K., Vandvik, P. O., Loeb, M., & Guyatt, G. H. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-12-201212180-00563 · Cited by 367
“Beausoleil et al, 2007 (33) 89 inpatients 44 68.”
BackgroundInfluentialLing, Z., Liu, X., Cheng, Y., Yan, X., & Wu, S. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2020.1867054 · Cited by 352
“…health in elderly subjects by increasing hypocholesterolemic and hypoglycemic effects (Fabersani et al. 2019), and preventing diarrheal diseases (Beausoleil et al. 2007), improving inflammatory disorders (Sharma et al. 2014), and preventing recurring infections (Guillemard et al. 2010), and…”
Backgroundvan Baarlen, P., Troost, F., van der Meer, C., Hooiveld, G., Boekschoten, M., Brummer, R. J. M., & Kleerebezem, M. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000079107 · Cited by 334
Antibiotic-Associated Diarrhea: Epidemiology, Trends and Treatment
McFarland, L. V. (2008) · Future Microbiology · doi:10.2217/17460913.3.5.563 · Cited by 333
“conducted a double-blind randomized study of hospitalized patients for the prevention of AAD using fermented milk with a mixture of two lactobacilli strains (Lactobacillus casei and Lactobacillus acidophilus CI1285) compared with placebo milk [99].”
BackgroundProbiotics and health: An evidence-based review
Aureli, P., Capurso, L., Castellazzi, A. M., Clerici, M., Giovannini, M., Morelli, L., Poli, A., Pregliasco, F., Salvini, F., & Zuccotti, G. V. (2011) · Pharmacological Research · doi:10.1016/j.phrs.2011.02.006 · Cited by 281
Probiotics for the prevention of pediatric antibiotic-associated diarrhea
Guo, Q., Goldenberg, J. Z., Humphrey, C., El Dib, R., & Johnston, B. C. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004827.pub5 · Cited by 275
“Beausoleil 2007 {published data only} Beausoleil M, Fortier N, Guénette S, L’ecuyer A, Savoie M, Franco M, et al. Effect of a fermented milk combining Lactobacillus acidophilus Cl1285 and Lactobacillus casei in the prevention of antibiotic-associated diarrhea: a randomized, double-blind,…”
BackgroundMethodShen, N. T., Maw, A., Tmanova, L. L., Pino, A., Ancy, K., Crawford, C. V., Simon, M. S., & Evans, A. T. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.02.003 · Cited by 273
New Approaches for Bacteriotherapy: Prebiotics, New-Generation Probiotics, and Synbiotics
Patel, R., & DuPont, H. L. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ177 · Cited by 267
Therapeutical use of probiotic formulations in clinical practice
Iannitti, T., & Palmieri, B. (2010) · Clinical Nutrition · doi:10.1016/j.clnu.2010.05.004 · Cited by 260
“112 designed a study to assess the efficacy and safety of a fermented milk combining L. acidophilus and L. casei that is widely available in Canada, in the prevention of antibiotic-associated diarrhea (AAD).”
BackgroundInclusion of Fermented Foods in Food Guides around the World
Chilton, S., Burton, J., & Reid, G. (2015) · Nutrients · doi:10.3390/nu7010390 · Cited by 249
“As fermented foods are known to provide benefits to managing some cardiovascular risk factors [66] and potentially even improve recovery post-infarction [67], the reduction by probiotic food intake of drug side effects [68,69], especially antibiotics [70,71], further”
BackgroundProbiotics for the prevention of pediatric antibiotic-associated diarrhea
Johnston, B. C., Goldenberg, J. Z., Vandvik, P. O., Sun, X., & Guyatt, G. H. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004827.pub3 · Cited by 222
Hungin, A. P. S., Mulligan, C., Pot, B., Whorwell, P., Agréus, L., Fracasso, P., Lionis, C., Mendive, J., Philippart de Foy, J.-M., Rubin, G., et al. (2013) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12460 · Cited by 212
Antibiotic-induced gut dysbiosis and barrier disruption and the potential protective strategies
Duan, H., Yu, L., Tian, F., Zhai, Q., Fan, L., & Chen, W. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2020.1843396 · Cited by 207
Chamberlain, R., & Lau, C. (2016) · International Journal of General Medicine · doi:10.2147/ijgm.s98280 · Cited by 177
“…22 McFarland et al (1995) 48 ) 50 Thomas et al (2001) 44 Plummer et al (2004) 51 Duman et al (2005) 42 Kotowska et al (2005) 52 Can et al (2006) 53 Beausoleil et al (2007) 45 Hickson et al (2007) 54 Rafiq et al (2007) 55 Miller et al (2008; a) 56 Miller et al (2008; b) 56 Ruszczynski et al (2008)…”
InfluentialBaldwin∗, C., Millette∗, M., Oth †, D., Ruiz, M. T., Luquet, F.-M., & Lacroix, M. (2010) · Nutrition and Cancer · doi:10.1080/01635580903407197 · Cited by 170
“casei) probiotic fermented milk was safe and effective in the prevention of antibiotic-associated diarrhea in hospitalized patients (15).”
BackgroundProbiotics in the prevention of antibiotic-associated diarrhoea and Clostridium difficile infection
Hickson, M. (2011) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x11399115 · Cited by 168
Goodman, C., Keating, G., Georgousopoulou, E., Hespe, C., & Levett, K. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-043054 · Cited by 163
Karska-Wysocki, B., Bazo, M., & Smoragiewicz, W. (2010) · Microbiological Research · doi:10.1016/j.micres.2009.11.008 · Cited by 161
Meta‐analysis: probiotics in antibiotic‐associated diarrhoea
Videlock, E. J., & Cremonini, F. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2012.05104.x · Cited by 158
Hungin, A. P. S., Mitchell, C. R., Whorwell, P., Mulligan, C., Cole, O., Agréus, L., Fracasso, P., Lionis, C., Mendive, J., Philippart de Foy, J. ‐., et al. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14539 · Cited by 154
AGA Technical Review on the Role of Probiotics in the Management of Gastrointestinal Disorders
Preidis, G. A., Weizman, A. V., Kashyap, P. C., & Morgan, R. L. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.05.060 · Cited by 127
Probiotics in the critically ill: A systematic review of the randomized trial evidence
Petrof, E. O., Dhaliwal, R., Manzanares, W., Johnstone, J., Cook, D., & Heyland, D. K. (2012) · Critical Care Medicine · doi:10.1097/ccm.0b013e318260cc33 · Cited by 132
Health-Promoting Properties of Lactobacilli in Fermented Dairy Products
Widyastuti, Y., Febrisiantosa, A., & Tidona, F. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.673890 · Cited by 135
Fox, M. J., Ahuja, K. D. K., Robertson, I. K., Ball, M. J., & Eri, R. D. (2015) · BMJ Open · doi:10.1136/bmjopen-2014-006474 · Cited by 117
Is primary prevention of Clostridium difficile infection possible with specific probiotics?
Johnson, S., Maziade, P.-J., McFarland, L. V., Trick, W., Donskey, C., Currie, B., Low, D. E., & Goldstein, E. J. C. (2012) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2012.06.005 · Cited by 117
Review on microbiota and effectiveness of probiotics use in older
Rondanelli, M. (2015) · World Journal of Clinical Cases · doi:10.12998/wjcc.v3.i2.156 · Cited by 115
McFarland, L. (2015) · Antibiotics · doi:10.3390/antibiotics4020160 · Cited by 109
“5 only 34% with VAP on abx nr pneumonia Morrow 2010 [29] adults, I 19 61% single 66% amox or cepha 49% resp Hickson 2007 [30] adults, I 0 nr 60% amp or cepha 80% resp or GU Dietrich 2014 [31] elderly, I 8 nr nr nr Plummer 2004 [32] adults, I 0 nr mixed nr Rafiq 2007 [33] adults, I 0 nr 48% ceph nr Stein 2007 [34] adul…”
BackgroundRole of Lactobacillus in the Prevention of Antibiotic‐Associated Diarrhea: A Meta‐analysis
Kale‐Pradhan, P. B., Jassaly, H. K., & Wilhelm, S. M. (2010) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.30.2.119 · Cited by 104
Agamennone, V., Krul, C. A. M., Rijkers, G. T., & Kort, R. (2018) · BMC Gastroenterology · doi:10.1186/s12876-018-0831-x · Cited by 115
“Of these, 11 detected a significant difference between treatment and placebo, including two studies that were underpowered according to their power analysis [56, 65].”
BackgroundPrebiotics, probiotics and synbiotics: an overview.
Sekhon, B. S., & Jairath, S. (2010) · Cited by 145
Pattani, R., Palda, V. A., Hwang, S. W., & Shah, P. S. (2013) · PubMed Central · Cited by 123
Probiotics and health: a review of the evidence
Weichselbaum, E. (2009) · Nutrition Bulletin · doi:10.1111/j.1467-3010.2009.01782.x · Cited by 115
Cai, J., Zhao, C., Du, Y., Zhang, Y., Zhao, M., & Zhao, Q. (2018) · United European Gastroenterology Journal · doi:10.1177/2050640617736987 · Cited by 72
Probiotics in the next-generation sequencing era
Suez, J., Zmora, N., & Elinav, E. (2020) · Gut Microbes · doi:10.1080/19490976.2019.1586039 · Cited by 81
“difficile infection.(30-60) Studies that did find a significant positive effect of probiotics in these conditions were associated with a rarely encountered C.”
BackgroundLiao, W., Chen, C., Wen, T., & Zhao, Q. (2020) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000001464 · Cited by 96
Probiotics for infectious diseases: more drugs, less dietary supplementation
Kotzampassi, K. E., & Giamarellos‐Bourboulis, E. J. (2012) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2012.06.006 · Cited by 91
Probiotics in the gastrointestinal diseases of the elderly
Malaguarnera, G., Leggio, F., Vacante, M., Motta, M., Giordano, M., Biondi, A., Basile, F., Mastrojeni, S., Mistretta, A., Malaguarnera, M., et al. (2012) · The Journal of nutrition, health and aging · doi:10.1007/s12603-011-0357-1 · Cited by 80
Hudson, L. E., Anderson, S. E., Corbett, A. H., & Lamb, T. J. (2016) · Clinical Microbiology Reviews · doi:10.1128/cmr.00049-16 · Cited by 85
Dylewski, J., Psaradellis, E., & Sampalis, J. (2010) · Archives of Medical Science · doi:10.5114/aoms.2010.13508 · Cited by 72
“The results of the current study are comparable with others that have reported the effectiveness of probiotics in reducing the incidence of AAD [9-11, 16, 17, 19-21].”
BackgroundMethodResultPreston, K., Krumian, R., Hattner, J., de Montigny, D., Stewart, M., & Gaddam, S. (2018) · Beneficial Microbes · doi:10.3920/bm2017.0105 · Cited by 70
Auclair, J., Frappier, M., & Millette, M. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ179 · Cited by 67
“Also, clinical trials conducted with this specific probiotic formulation demonstrated safety and efficacy in reducing the incidences of AAD and CDI in hospitalized patients.”
BackgroundInfluentialMcFarland, L. V., Ship, N., Auclair, J., & Millette, M. (2018) · Journal of Hospital Infection · doi:10.1016/j.jhin.2018.04.017 · Cited by 62
Jafarnejad, S., Shab‐Bidar, S., Speakman, J. R., Parastui, K., Daneshi‐Maskooni, M., & Djafarian, K. (2016) · Nutrition in Clinical Practice · doi:10.1177/0884533616639399 · Cited by 68
Pathway to Prevention of Nosocomial Clostridium difficile Infection
Goldstein, E. J. C., Johnson, S., Maziade, P.-J., McFarland, L. V., Trick, W. E., Dresser, L., Millette, M., Mazloum, H., & Low, D. E. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ142 · Cited by 70
Probiotics for antibiotic-associated diarrhea: Do we have a verdict?
Issa, I., & Moucari, R. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i47.17788 · Cited by 63
Forty-five-year evolution of probiotic therapy
Puebla-Barragan, S., & Reid, G. (2019) · Microbial Cell · doi:10.15698/mic2019.04.673 · Cited by 55
Prevention of Clostridium difficile Infection With Probiotics
Evans, C. T., & Johnson, S. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ138 · Cited by 72
Maziade, P.-J., Pereira, P., & Goldstein, E. J. C. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ178 · Cited by 60
“itous, given recently published data from randomized controlled trials using this same formulation [4, 12, 13].”
Song, H. J., Kim, J.-Y., Jung, S.-A., Kim, S.-E., Park, H.-S., Jeong, Y., Hong, S. P., Cheon, J. H., Kim, W. H., Kim, H.-J., et al. (2010) · Journal of Korean Medical Science · doi:10.3346/jkms.2010.25.12.1784 · Cited by 58
“These include the synthesis of antimicrobial substances (17, 22, 26), competition for nutrients required for the growth of pathogens, competitive inhibition of adhesion of pathogens, and modification of toxins or toxin receptors (27).”
BackgroundProbiotic bacteria as modulators of cellular senescence: emerging concepts and opportunities
Sharma, R., & Padwad, Y. S. (2019) · Gut Microbes · doi:10.1080/19490976.2019.1697148 · Cited by 56
Zhang, L., Zeng, X., Guo, D., Zou, Y., Gan, H., & Huang, X. (2022) · BMC Geriatrics · doi:10.1186/s12877-022-03257-3 · Cited by 61
“Beausoleil, 2007 [19] Canada Hospital Lactobacillus acidophilus and Lactobacillus casei.”
BackgroundSafdar, N., Barigala, R., Said, A., & McKinley, L. (2008) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.2008.00980.x · Cited by 50
“Immunocompromised 7 ⁄ 23 (31) 8 ⁄ 16 (50) 0Æ21 Renal disease 5 ⁄ 23 (22) 3 ⁄ 16 (19) 0Æ38 Proton pump inhibitor use 7 ⁄ 23 (31) 8 ⁄ 16 (50) 0Æ19”
BackgroundAn introduction of the role of probiotics in human infections and autoimmune diseases
Sales‐Campos, H., Soares, S. D. C., & Oliveira, C. J. F. (2019) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2019.1621261 · Cited by 56
Rätsep, M., Kõljalg, S., Sepp, E., Smidt, I., Truusalu, K., Songisepp, E., Štšepetova, J., Naaber, P., Mikelsaar, R.-H., & Mikelsaar, M. (2017) · Anaerobe · doi:10.1016/j.anaerobe.2017.03.019 · Cited by 47
Probiotics: insights and new opportunities for Clostridioides difficile intervention
Pal, R., Athamneh, A. I. M., Deshpande, R., Ramirez, J. A. R., Adu, K. T., Muthuirulan, P., Pawar, S., Biazzo, M., Apidianakis, Y., Sundekilde, U. K., et al. (2022) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2022.2072705 · Cited by 51
Probiotics and prevention of Clostridium difficile infection
Goldstein, E. J. C., Johnson, S., Maziade, P.-J., Evans, C. T., Sniffen, J. C., Millette, M., & McFarland, L. V. (2016) · Anaerobe · doi:10.1016/j.anaerobe.2016.12.007 · Cited by 46
Ma, Y., Yang, J. Y., Peng, X., Xiao, K. Y., Xu, Q., & Wang, C. (2020) · Journal of Digestive Diseases · doi:10.1111/1751-2980.12839 · Cited by 44
“2 | Primary outcome: incidence rate of AAD Nine of our included RCTs assessed the incidence rate of AAD.(25-33) Significant differences were found in the overall results (OR 0.”
BackgroundRen, D., Wang, D., Liu, H., Shen, M., & Yu, H. (2019) · Food and Agricultural Immunology · doi:10.1080/09540105.2019.1579785 · Cited by 48
“A study showed that lactic acid bacteria can induce increased levels of cytokines interleukin (IL)-12 and tumor necrosis factor (TNF)-α, promote T helper 1 (Th1) immune response, and inhibit Th2 type immune response (Beausoleil et al., 2007; Zhu et al., 2018).”
BackgroundSpinler, J. K., Ross, C. L., & Savidge, T. (2016) · Anaerobe · doi:10.1016/j.anaerobe.2016.05.007 · Cited by 46
Changes of probiotic fermented drink obtained from soy and rice byproducts during cold storage
Costa, K. K. F. D., Júnior, M. S. S., Rosa, S. I. R., Caliari, M., & Pimentel, T. C. (2016) · LWT · doi:10.1016/j.lwt.2016.12.017 · Cited by 43
Characterization of probiotic properties ofLactobacillusstrains
Millette, M., Luquet, F. M., Ruiz, M. T., & Lacroix, M. (2008) · Dairy Science and Technology · doi:10.1051/dst:2008018 · Cited by 49
Maziade, P.-J., Andriessen, J. A., Pereira, P., Currie, B., & Goldstein, E. J. C. (2013) · Current Medical Research and Opinion · doi:10.1185/03007995.2013.833501 · Cited by 40
Desrouillères, K., Millette, M., Vu, K. D., Touja, R., & Lacroix, M. (2015) · Journal of Functional Foods · doi:10.1016/j.jff.2015.06.035 · Cited by 68
World Gastroenterology Organisation practice guideline: Probiotics and prebiotics
(2009) · Arab Journal of Gastroenterology · doi:10.1016/j.ajg.2009.03.001 · Cited by 52
Probiotics and Prebiotics in Elderly Individuals
Salminen, S., Satokari, R. M., Rantanen, R., & Pitkälä, K. H. (2009) · CRC Press eBooks · doi:10.1201/9781420062151.ch16 · Cited by 38
Forssten, S. D., Korczyńska, M. Z., Zwijsen, R. M. L., Noordman, W. H., Madetoja, M., & Ouwehand, A. C. (2013) · Appetite · doi:10.1016/j.appet.2013.06.093 · Cited by 37
Manus, J., Millette, M., Aguilar‐Uscanga, B. R., Salmieri, S., Maherani, B., & Lacroix, M. (2021) · Journal of Food Science · doi:10.1111/1750-3841.15859 · Cited by 37
FRIEDMAN, G. J. (2012) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2012.08.002 · Cited by 39
Mallina, R. K., Craik, J., Briffa, N., Ahluwalia, V., Clarke, J., & Cobb, A. G. (2017) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2017.04.001 · Cited by 34
Bednárik, D. S., Földvári-Nagy, K. C., Simon, V., Rancz, A., Gede, N., Veres, D. S., Paraskevopoulos, P., Schnabel, T., Erőss, B. M., Hegyi, P., et al. (2025) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2024.101151 · Cited by 35
van Wietmarschen, H., Busch, M., van Oostveen, A., Pot, G. K., & Jong, M. C. (2020) · BMC Gastroenterology · doi:10.1186/s12876-020-01297-w · Cited by 37
EL‐SALAM, M. H. A., Hippen, A. R., El-Shafei, K., Assem, F. M., Abbas, H. M., El‐Aziz, M. A., Sharaf, O. M., & El-Aassar, M. (2011) · International Journal of Food Science & Technology · doi:10.1111/j.1365-2621.2011.02722.x · Cited by 32
Use of probiotics in prevention and treatment of patients with Clostridium difficile infection
Ollech, J. E., Shen, N. T., Crawford, C. V., & Ringel, Y. (2016) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2016.01.002 · Cited by 37
Sinclair, A., Xie, X., Saab, L., & Dendukuri, N. (2016) · CMAJ Open · doi:10.9778/cmajo.20160087 · Cited by 33
Bugs and Guts: Practical Applications of Probiotics for Gastrointestinal Disorders in Children
Barnes, D. M., & Yeh, A. M. (2015) · Nutrition in Clinical Practice · doi:10.1177/0884533615610081 · Cited by 34
Probiotics for the Prevention and Treatment of Antibiotic-Associated Diarrhea
Hempel, S., Newberry, S. J., Maher, A. R., Wang, Z., Miles, J. N. V., Shanman, R., & Shekelle, P. (2012) · Cited by 33
Leal, J. R., Heitman, S. J., Conly, J. M., Henderson, E. A., & Manns, B. (2016) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2016.134 · Cited by 27
Heil, E. L., Harris, A. D., Brown, C. H., Seung, H., Thom, K. A., von Rosenvinge, E. C., Sorongon, S., Pineles, L. L., Goodman, K. E., & Leekha, S. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab417 · Cited by 29
Savings from the use of a probiotic formula in the prophylaxis of antibiotic-associated diarrhea
Fansi, A. K., Guertin, J. R., & LeLorier, J. (2011) · Journal of Medical Economics · doi:10.3111/13696998.2011.629015 · Cited by 30
“We are confident that this would be the case since the efficacy of the probiotic formula as reported by Gao et al.10 is similar to the one reported by Beausoleil et al.7 in a Canadian teaching hospital.”
MethodResultInfluentialClostridium difficile Infection
Shin, J. H., Chaves‐Olarte, E., & Warren, C. A. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.ei10-0007-2015 · Cited by 27
Investigational new treatments for Clostridium difficile infection
Ivarsson, M. E., Leroux, J., & Castagner, B. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.12.003 · Cited by 33
Velasco, M., Requena, T., Delgado-Iribarren, A., Peláez, C., & Guijarro, C. (2019) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000001131 · Cited by 25
Wachholz, P. A., Nunes, V. D. S., Polachini do Valle, A., Jacinto, A. F., & Villas-Boas, P. J. F. (2018) · Age and Ageing · doi:10.1093/ageing/afy006 · Cited by 20
“Six studies did not clearly report the random sequence generation nor the allocation concealment [10, 11, 15, 19, 24, 25].”
BackgroundProbiotics for the prevention of Clostridioides difficile-associated diarrhea in adults and children
Esmaeilinezhad, Z., Ghosh, N., Walsh, C. M., Steen, J. P., Burgman, A. M., Mertz, D., & Johnston, B. C. (2025) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006095.pub5 · Cited by 26
Vitetta, L., Manuel, R., Zhou, J., Linnane, A. W., Hall, S., & Coulson, S. (2014) · Pharmaceuticals · doi:10.3390/ph7090954 · Cited by 24
Dridi, C., Millette, M., Aguilar‐Uscanga, B. R., Manus, J., Salmieri, S., & Lacroix, M. (2021) · Foods · doi:10.3390/foods10102259 · Cited by 22
Carlsson, M., Gustafson, Y., Håglin, L., & Eriksson, S. (2009) · The journal of nutrition health & aging · doi:10.1007/s12603-009-0218-3 · Cited by 23
Probiotics for the Prevention of Clostridium difficile–Associated Diarrhea
Johnston, B. C., Goldenberg, J. Z., & Guyatt, G. H. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-9-201305070-00019 · Cited by 24
Lin, S., Zhao, S., Liu, J., Zhang, J., Zhang, C., Hao, H., Sun, Y., Cai, J., Yang, Y., Ma, Y., et al. (2019) · Food & Function · doi:10.1039/c9fo01583c · Cited by 23
Dairy associations for the targeted control of opportunistic Candida
Aitzhanova, A., Oleinikova, Y., Mounier, J., Hymery, N., Salas, M. L., Amangeldi, A., Saubenova, M., Alimzhanova, M. B., Ashimuly, K., & САДАНОВ, А. К. (2021) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-021-03096-1 · Cited by 23
Yang, J., Meng, L., Li, Y., & Huang, H. (2023) · Food & Function · doi:10.1039/d3fo02110f · Cited by 21
Trick, W. E., Sokalski, S. J., Johnson, S., Bunnell, K. L., Levato, J., Ray, M. J., & Weinstein, R. A. (2018) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2018.76 · Cited by 20
McFarland, L. V. (2016) · International Journal of General Medicine · doi:10.2147/ijgm.s119970 · Cited by 18
Probiotics, Critical Illness, and Methodologic Bias
Koretz, R. L. (2009) · Nutrition in Clinical Practice · doi:10.1177/0884533608329296 · Cited by 19
Metadata
- Authors
- Beausoleil, M., Fortier, N., Guénette, S., L’Ecuyer, A., Savoie, M., Franco, M., Lachaîne, J., & Weiss, K.
- Affiliations
- Hôpital Maisonneuve-Rosemont (CA)
- Université de Montréal (CA)
- Corresponding author
- Beausoleil, Mélanie
- ORCID
- Lachaîne, Jean
- Venue
- Canadian Journal of Gastroenterology
- Publisher
- Hindawi Limited
- Published
- 2007
- Volume
- 21
- Issue
- 11
- Pages
- 732-736
- ISSN
- 0835-7900 (ISSN-L)
- PMC
- PMC2658588
- OpenAlex
- W2147619842
- Cited by
- 162
- References
- 26
- Citations by year
- 2025: 4 · 2024: 4 · 2023: 6 · 2022: 6 · 2021: 11 · 2020: 7 · 2019: 11 · 2018: 9 · 2017: 9 · 2016: 14 · 2015: 15 · 2014: 8 · 2013: 12 · 2012: 11
- FWCI
- 14.11
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Canadian Journal of Gastroenterology (publishedVersion, cc-by)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- American College of Gastroenterology
- Topics
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- antibiotic-associated diarrhea, probiotics, fermented milk, Lactobacillus acidophilus, Lactobacillus casei, hospitalized patients, diarrhea prevention, probiotic safety
- MeSH terms
- Aged, Aged, 80 and over, Animals, Anti-Bacterial Agents, Diarrhea, Double-Blind Method, Female, Fermentation, Humans, Lactobacillus acidophilus, Lacticaseibacillus casei, Length of Stay, Male, Middle Aged, Milk, Odds Ratio, Treatment Outcome, Probiotics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.